Sarepta Therapeutics, Inc. (LON:0L35)
London
· Delayed Price · Currency is GBP · Price in USD 106.30
-2.69 (-2.47%)
At close: Feb 21, 2025
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 8.03 billion as of February 21, 2025. Its market cap has decreased by -14.53% in one year.
Market Cap
8.03B
Enterprise Value
8.20B
Revenue
1.22B
Ranking
n/a
PE Ratio
88.34
Stock Price
106.30
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 43.06M to 8.03B, an increase of 18,549.07%. That is a compound annual growth rate of 20.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |